VANGUARD THERAPEUTICS (P) LIMITED.-COMPANY INSIGHT - TF Market Research

VANGUARD THERAPEUTICS (P) LIMITED.-COMPANY INSIGHT

21 pages — Published Sep 12, 2008
Price $1,495.00  |  Buy this Report Now
  
This report is also available for purchase on a per-page basis.

About This Report

  
Brief Excerpt:
...##/#, Near Andhra Bank, Sanjeev Reddy Nagar, Hyderabad, ######, Andhra Pradesh, India email: info@vanguardtherapeutics.com Website: http://www.vanguardtherapeutics.com phone: ##-##-######## ...
  
Source:
LIFE SCIENCE ANALYTICS
Author:
HARINATHA, G.
Company
VANGUARD THERAPEUTICS
Geographic Regions
ASIA , INDIA , SOUTHERN ASIA
Non-Billable Page Numbers
2
Format:
PDF Adobe Acrobat
Sections
TitleStarting PageNumber of Pages
Company Information11
Vanguard Therapeutics (P) Limited. [NonUS -- Symbol : Private]11
Business Summary11
Product Glance31
Diseasehub Classification31
Product Summary41
Partner42
Condition Treated Trial Phase51
Product Details51
1. Orclomol Description61
Therapeutic Current Trial Trial Details Last Updated 2. Orclomol Description61
Therapeutic Drug Class Current Trial Trial Details Last Updated 3. PGI-MR Description61
Therapeutic Drug Class Current Trial Trial Details Last Updated 4. Flaser-D Description61
Therapeutic Drug Class Current Trial Trial Details Last Updated 5. Sozo Description61
Therapeutic Drug Class Current Trial Trial Details Last Updated 8. Neuropose Description71
Therapeutic Drug Class Current Trial Trial Details Last Updated 9. Ciprogard Description71
Therapeutic Drug Class Current Trial Trial Details Last Updated 10. Gentaven Description71
Therapeutic Drug Class Current Trial Trial Details Last Updated 11. Dewax Description81
Therapeutic Current Trial Trial Details81
Last Updated 12. Dewax-AF Description81
Last Updated 13. ATP-30 Description81
Therapeutic Drug Class Current Trial M Trial Details Last Updated 15. Normoten-AM81
Description92
Therapeutic Drug Class Current Trial Trial Details Last Updated 16. Loten Description91
Therapeutic Drug Class Current Trial Trial Details Last Updated 17. LAT Description91
Therapeutic Drug Class Current Trial Trial Details Last Updated 19. Hyten Description91
Therapeutic Drug Class Current Trial Trial Details Last Updated 20. Maxcet-L91
Therapeutic Drug Class Current Trial Trial Details Last Updated 21. Flaser Description101
Therapeutic Current Trial Trial Details Last Updated 22. Sucromet Description101
Therapeutic Drug Class Current Trial Trial Details Last Updated 23. Mycoz Description101
Therapeutic Drug Class Current Trial Trial Details Last Updated 24. Orovin Description101
Therapeutic Drug Class Current Trial Trial Details Last Updated 25. Phytocan Description101
Therapeutic Drug Class Current Trial Trial Details Last Updated 26. Urolactone Description111
Therapeutic Drug Class Current Trial Trial Details Last Updated 27. Systolyte Description111
Therapeutic Current Trial Trial Details Last Updated 28. Laab Description111
Therapeutic Current Trial Trial Details Last Updated 29. Benspore Description111
Therapeutic Current Trial Trial Details Last Updated 30. Utercon Description111
Therapeutic Current Trial Trial Details Last Updated 31. Vip-Z111
Description121
Therapeutic Drug Class Current Trial Trial Details121
Therapeutic Drug Class Current Trial Trial Details Last Updated 33. B-banc Description121
Therapeutic Current Trial Trial Details121
Last Updated 34. Cefigard Description121
Therapeutic Drug Class Current Trial Trial Details Last Updated 35. Polyminth Description121
Last Updated 36. Septigard Description131
Therapeutic Drug Class Current Trial Trial Details Last Updated 37. Rosq Description131
Therapeutic Drug Class Current Trial Trial Details Last Updated 38. Q9 Description131
Therapeutic Drug Class Current Trial Trial Details Last Updated 39. M.P. Description131
Therapeutic Drug Class Current Trial Trial Details Last Updated 40. Septigard Description131
Therapeutic Drug Class Current Trial Trial Details Last Updated131
41. Neurogard Description141
Therapeutic Current Trial Trial Details Last Updated 42. Impro Description141
Therapeutic Current Trial Trial Details Last Updated 43. Imuplex Description141
Therapeutic Current Trial Trial Details Last Updated 44. Brodil Description141
Therapeutic Drug Class Current Trial Trial Details Last Updated 45. Brodil Description141
Therapeutic Drug Class Current Trial Trial Details Last Updated 46. Brodil- D Description141
Therapeutic Drug Class Current Trial Trial Details Last Updated 47. Tuscory Description151
Therapeutic Drug Class Current Trial Trial Details Last Updated 48. E.T.phyllin Description151
Therapeutic Drug Class Current Trial Trial Details Last Updated 49. Norkold Description151
Therapeutic Drug Class Current Trial Trial Details Last Updated 50. Sestil Description151
Therapeutic Drug Class Current Trial Trial Details Last Updated 51. Sestil-AD Description151
Therapeutic Drug Class Current Trial Trial Details Last Updated 52. Falcon-OZ Description161
Therapeutic Drug Class Current Trial Trial Details Last Updated 53. API-20 Description161
Therapeutic Drug Class Current Trial Trial Details Last Updated 54. Pexel Description161
Therapeutic Drug Class Current Trial Trial Details Last Updated 55. Pexel-D Description161
Therapeutic Drug Class Current Trial Trial Details Last Updated 56. Megaspas Description161
Therapeutic Current Trial Trial Details Last Updated 57. Pyridoxyl Description171
Therapeutic Current Trial M Trial Details Last Updated 58. Prestozyme Description171
Therapeutic Current Trial M Trial Details Last Updated 59. Robopeptin Description171
Therapeutic Current Trial Trial Details Last Updated 60. Tyfy Description171
Therapeutic Drug Class Current Trial Trial Details Last Updated 61. Acet Description171
Therapeutic171
Drug Class Current Trial M Trial Details Last Updated 62. Prestogesic Description181
Therapeutic Drug Class Current Trial Trial Details Last Updated 63. Dolograde Description181
Therapeutic Drug Class Current Trial Trial Details Last Updated 64. PGI Description181
Therapeutic Current Trial Trial Details Last Updated 65. Spinn Description181
Therapeutic Drug Class Current Trial Trial Details181
Last Updated183
Management Profile211
Koteswara Rao Potineni -- Founder and Managing Director211
Swetha Potineni -- Director211
Vindhya Rani Potineni -- Director211
Subba Rao Ambati -- Director211

Table Of Contents

TF Market Research® reports contain in-depth primary research and statistics, market trends, forecasts, segment analysis and much more from over 100 top consulting, market research and business publishing sources. The service is updated daily.

About the Author


Cite this Report

  
MLA:
TF Market Research. "VANGUARD THERAPEUTICS (P) LIMITED.-COMPANY INSIGHT" Sep 12, 2008. Alacra Store. May 22, 2013. <http://www.alacrastore.com/storecontent/markintel/LIFE_SCIENCE_ANALYTICS-50233248>
  
APA:
TF Market Research. (2008). VANGUARD THERAPEUTICS (P) LIMITED.-COMPANY INSIGHT Sep 12, 2008. New York, NY: Alacra Store. Retrieved May 22, 2013 from <http://www.alacrastore.com/storecontent/markintel/LIFE_SCIENCE_ANALYTICS-50233248>
  
$1,495.00
$  £  €
Have a Question?
Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.
More Research
Search all our Market Research from one place.